PomDoctor (POM) a leading Chinese online medical platform for chronic diseases, priced its initial public offering at $4.00 per ADS.
The company is offering 5M ADSs, with six ADSs representing one Class A ordinary share.
Gross proceeds are expected to total ~$20M.
ADSs will begin trading on the Nasdaq Global Market on October 8, 2025, under the ticker symbol “POM.”
The company has also granted underwriters a 45-day option to purchase up to 750,000 additional ADSs at the offering price.
The offering is expected to close on or about October 9, 2025.
Source: Press release
The company is offering 5M ADSs, with six ADSs representing one Class A ordinary share.
Gross proceeds are expected to total ~$20M.
ADSs will begin trading on the Nasdaq Global Market on October 8, 2025, under the ticker symbol “POM.”
The company has also granted underwriters a 45-day option to purchase up to 750,000 additional ADSs at the offering price.
The offering is expected to close on or about October 9, 2025.
Source: Press release
